Article Details

AbbVie to Buy Neuroscience Biotech Firm Cerevel for $8.7 Billion - BNN Bloomberg

Retrieved on: 2023-12-06 22:12:23

Tags for this article:

Click the tags to see associated articles and topics

AbbVie to Buy Neuroscience Biotech Firm Cerevel for $8.7 Billion - BNN Bloomberg. View article details on hiswai:

Excerpt

AbbVie to Buy Neuroscience Biotech Firm Cerevel for $8.7 Billion. Madison Muller, Bloomberg News. (Bloomberg) -- AbbVie Inc. agreed to buy Cerevel ...

Article found on: www.bnnbloomberg.ca

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo